Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial

<p>Abstract</p> <p>Background</p> <p>Several uncontrolled studies of hyperbaric treatment in children with autism have reported clinical improvements; however, this treatment has not been evaluated to date with a controlled study. We performed a multicenter, randomized,...

Full description

Bibliographic Details
Main Authors: Usman Anju, Logerquist Sally, Schneider Cindy, Smith Scott, Rossignol Lanier W, Rossignol Daniel A, Neubrander Jim, Madren Eric M, Hintz Gregg, Grushkin Barry, Mumper Elizabeth A
Format: Article
Language:English
Published: BMC 2009-03-01
Series:BMC Pediatrics
Online Access:http://www.biomedcentral.com/1471-2431/9/21
id doaj-475799903fa4481bb1186308c3b551d1
record_format Article
spelling doaj-475799903fa4481bb1186308c3b551d12020-11-24T22:24:40ZengBMCBMC Pediatrics1471-24312009-03-01912110.1186/1471-2431-9-21Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trialUsman AnjuLogerquist SallySchneider CindySmith ScottRossignol Lanier WRossignol Daniel ANeubrander JimMadren Eric MHintz GreggGrushkin BarryMumper Elizabeth A<p>Abstract</p> <p>Background</p> <p>Several uncontrolled studies of hyperbaric treatment in children with autism have reported clinical improvements; however, this treatment has not been evaluated to date with a controlled study. We performed a multicenter, randomized, double-blind, controlled trial to assess the efficacy of hyperbaric treatment in children with autism.</p> <p>Methods</p> <p>62 children with autism recruited from 6 centers, ages 2–7 years (mean 4.92 ± 1.21), were randomly assigned to 40 hourly treatments of either hyperbaric treatment at 1.3 atmosphere (atm) and 24% oxygen ("treatment group", n = 33) or slightly pressurized room air at 1.03 atm and 21% oxygen ("control group", n = 29). Outcome measures included Clinical Global Impression (CGI) scale, Aberrant Behavior Checklist (ABC), and Autism Treatment Evaluation Checklist (ATEC).</p> <p>Results</p> <p>After 40 sessions, mean physician CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0008), receptive language (p < 0.0001), social interaction (p = 0.0473), and eye contact (p = 0.0102); 9/30 children (30%) in the treatment group were rated as "very much improved" or "much improved" compared to 2/26 (8%) of controls (p = 0.0471); 24/30 (80%) in the treatment group improved compared to 10/26 (38%) of controls (p = 0.0024). Mean parental CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0336), receptive language (p = 0.0168), and eye contact (p = 0.0322). On the ABC, significant improvements were observed in the treatment group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group. In the treatment group compared to the control group, mean changes on the ABC total score and subscales were similar except a greater number of children improved in irritability (p = 0.0311). On the ATEC, sensory/cognitive awareness significantly improved (p = 0.0367) in the treatment group compared to the control group. Post-hoc analysis indicated that children over age 5 and children with lower initial autism severity had the most robust improvements. Hyperbaric treatment was safe and well-tolerated.</p> <p>Conclusion</p> <p>Children with autism who received hyperbaric treatment at 1.3 atm and 24% oxygen for 40 hourly sessions had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children who received slightly pressurized room air.</p> <p>Trial Registration</p> <p>clinicaltrials.gov NCT00335790</p> http://www.biomedcentral.com/1471-2431/9/21
collection DOAJ
language English
format Article
sources DOAJ
author Usman Anju
Logerquist Sally
Schneider Cindy
Smith Scott
Rossignol Lanier W
Rossignol Daniel A
Neubrander Jim
Madren Eric M
Hintz Gregg
Grushkin Barry
Mumper Elizabeth A
spellingShingle Usman Anju
Logerquist Sally
Schneider Cindy
Smith Scott
Rossignol Lanier W
Rossignol Daniel A
Neubrander Jim
Madren Eric M
Hintz Gregg
Grushkin Barry
Mumper Elizabeth A
Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
BMC Pediatrics
author_facet Usman Anju
Logerquist Sally
Schneider Cindy
Smith Scott
Rossignol Lanier W
Rossignol Daniel A
Neubrander Jim
Madren Eric M
Hintz Gregg
Grushkin Barry
Mumper Elizabeth A
author_sort Usman Anju
title Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
title_short Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
title_full Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
title_fullStr Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
title_full_unstemmed Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
title_sort hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial
publisher BMC
series BMC Pediatrics
issn 1471-2431
publishDate 2009-03-01
description <p>Abstract</p> <p>Background</p> <p>Several uncontrolled studies of hyperbaric treatment in children with autism have reported clinical improvements; however, this treatment has not been evaluated to date with a controlled study. We performed a multicenter, randomized, double-blind, controlled trial to assess the efficacy of hyperbaric treatment in children with autism.</p> <p>Methods</p> <p>62 children with autism recruited from 6 centers, ages 2–7 years (mean 4.92 ± 1.21), were randomly assigned to 40 hourly treatments of either hyperbaric treatment at 1.3 atmosphere (atm) and 24% oxygen ("treatment group", n = 33) or slightly pressurized room air at 1.03 atm and 21% oxygen ("control group", n = 29). Outcome measures included Clinical Global Impression (CGI) scale, Aberrant Behavior Checklist (ABC), and Autism Treatment Evaluation Checklist (ATEC).</p> <p>Results</p> <p>After 40 sessions, mean physician CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0008), receptive language (p < 0.0001), social interaction (p = 0.0473), and eye contact (p = 0.0102); 9/30 children (30%) in the treatment group were rated as "very much improved" or "much improved" compared to 2/26 (8%) of controls (p = 0.0471); 24/30 (80%) in the treatment group improved compared to 10/26 (38%) of controls (p = 0.0024). Mean parental CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0336), receptive language (p = 0.0168), and eye contact (p = 0.0322). On the ABC, significant improvements were observed in the treatment group in total score, irritability, stereotypy, hyperactivity, and speech (p < 0.03 for each), but not in the control group. In the treatment group compared to the control group, mean changes on the ABC total score and subscales were similar except a greater number of children improved in irritability (p = 0.0311). On the ATEC, sensory/cognitive awareness significantly improved (p = 0.0367) in the treatment group compared to the control group. Post-hoc analysis indicated that children over age 5 and children with lower initial autism severity had the most robust improvements. Hyperbaric treatment was safe and well-tolerated.</p> <p>Conclusion</p> <p>Children with autism who received hyperbaric treatment at 1.3 atm and 24% oxygen for 40 hourly sessions had significant improvements in overall functioning, receptive language, social interaction, eye contact, and sensory/cognitive awareness compared to children who received slightly pressurized room air.</p> <p>Trial Registration</p> <p>clinicaltrials.gov NCT00335790</p>
url http://www.biomedcentral.com/1471-2431/9/21
work_keys_str_mv AT usmananju hyperbarictreatmentforchildrenwithautismamulticenterrandomizeddoubleblindcontrolledtrial
AT logerquistsally hyperbarictreatmentforchildrenwithautismamulticenterrandomizeddoubleblindcontrolledtrial
AT schneidercindy hyperbarictreatmentforchildrenwithautismamulticenterrandomizeddoubleblindcontrolledtrial
AT smithscott hyperbarictreatmentforchildrenwithautismamulticenterrandomizeddoubleblindcontrolledtrial
AT rossignollanierw hyperbarictreatmentforchildrenwithautismamulticenterrandomizeddoubleblindcontrolledtrial
AT rossignoldaniela hyperbarictreatmentforchildrenwithautismamulticenterrandomizeddoubleblindcontrolledtrial
AT neubranderjim hyperbarictreatmentforchildrenwithautismamulticenterrandomizeddoubleblindcontrolledtrial
AT madrenericm hyperbarictreatmentforchildrenwithautismamulticenterrandomizeddoubleblindcontrolledtrial
AT hintzgregg hyperbarictreatmentforchildrenwithautismamulticenterrandomizeddoubleblindcontrolledtrial
AT grushkinbarry hyperbarictreatmentforchildrenwithautismamulticenterrandomizeddoubleblindcontrolledtrial
AT mumperelizabetha hyperbarictreatmentforchildrenwithautismamulticenterrandomizeddoubleblindcontrolledtrial
_version_ 1725760245702066176